US Stock Futures Up; All Eyes On Fed Decision - FactSet Research Systems (NYSE:FDS)

Pre-open movers

US stock futures traded higher in early pre-market trade. The FOMC will announce its policy decision at 2:00 p.m. ET, while the Fed Chairwoman Janet Yellen will hold a press conference at 2:30 p.m. ET. Futures for the Dow Jones Industrial Average climbed 32.50 points to 17,858.50, while the Standard & Poor's 500 index futures rose 3.05 points to 2,092.05. Futures for the Nasdaq 100 index gained 3.05 points to 4,454.80.

A Peek Into Global Markets

European markets were lower today, with the Spanish Ibex Index falling 0.24 percent, STOXX Europe 600 Index declining 0.31 percent and German DAX 30 index dropping 0.24 percent. French CAC 40 Index slipped 0.75 percent and London's FTSE 100 Index fell 0.49 percent. In Asian markets, Japan's Nikkei Stock Average fell 0.19 percent, China's Shanghai Composite Index climbed 1.65 percent, Hong Kong's Hang Seng Index gained 0.70 percent and India's BSE Sensex rose 0.55 percent.

Broker Recommendation

Analysts at BTIG Research upgraded

FactSet Research SystemsFDS

from Sell to Neutral. FactSet Research shares fell 2.27 percent to close at $161.74 yesterday.

Breaking news

Medivation Inc MDVN and Astellas announced today that the first patients have been enrolled in TRUMPET (Treatment Registry for Outcomes in CRPC Patients), a prospective observational patient registry designed to better understand the unique needs and treatment patterns for patients with castration-resistant prostate cancer (CRPC). To read the full news, click here.
Allergan plc AGN and KYTHERA Biopharmaceuticals, Inc. KYTH today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire KYTHERA in a cash and equity transaction valued at $75 per KYTHERA share, or approximately $2.1 billion, subject to the fulfillment of certain customary conditions summarized below. To read the full news, click here.
Tonix Pharmaceuticals Holding Corp. TNXP today reported that the U.S. Food and Drug Administration (FDA) has conditionally accepted the proposed trade name Tonmya™ (ton-MY-ah) for TNX-102 SL (cyclobenzaprine HCl sublingual tablets), 2.8 mg, for the management of fibromyalgia. To read the full news, click here.
Synergy Pharmaceuticals Inc. SGYP today announced positive top-line results from the first of two pivotal phase 3 clinical trials evaluating the efficacy and safety of two different plecanatide treatment doses (3.0 mg and 6.0 mg), taken as a tablet once-a-day, in 1,346 adult patients with chronic idiopathic constipation (CIC). To read the full news, click here.

Market News and Data brought to you by Benzinga APIs